Medical workers transfer a suspected coronavirus patient to an ambulance from the World Dream cruise ship at Kai Tak Cruise Terminal in Hong Kong on February 3. Photo: Sam Tsang

Who owns the coronavirus cure? China’s move to patent Gilead’s experimental drug for the novel virus could lead to legal wrangle

Name: SCMP
Telephone: +852-2680-8888

Institute of Virology in Wuhan, the epicentre of the global coronavirus outbreak, filed a patent for Gilead’s remdesivir antiviral drug on January 21
In a statement to the Post, California-based Gilead said it applied for a global patent in 2016, including in China, for using the drug to treat all coronavirus-linked illnesses

Topic | Pharmaceuticals

Eric Ng

Published: 8:00am, 6 Feb, 2020

Updated: 6:00pm, 14 Feb, 2020

Medical workers transfer a suspected coronavirus patient to an ambulance from the World Dream cruise ship at Kai Tak Cruise Terminal in Hong Kong on February 3. Photo: Sam Tsang

READ FULL ARTICLE

Eric Ng

Eric joined the SCMP in 1998 after brief stints in a trading company and translation and editing roles at Dow Jones and Edinburgh Financial Publishing. He has close to 20 years of experience covering China's energy, mining and industrial materials sectors, and has recently added biotechnology to his coverage. Eric has a Masters of Business Administration degree.